MICARDIS ANLO

This brand name is authorized in Brazil.

Active ingredients

The drug MICARDIS ANLO contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Amlodipine UNII `864V2Q084H` - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine
`2`	Telmisartan UNII `U5SYW473RQ` - TELMISARTAN
	Telmisartan is an orally active and specific angiotensin II receptor (type AT₁) antagonist. Telmisartan selectively binds the AT₁ receptor. The binding is long-lasting.
	Read more about Telmisartan

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DB04	Telmisartan and amlodipine	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DB Angiotensin II antagonists and calcium channel blockers
Discover more medicines within C09DB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	504505601111314, 504505604110319, 504505606113315, 504505607111316, 504505608116311

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.